12


/ Press Releases
2020-10
TWi’ ANDA for Dimethyl Fumarate DR Capsules (equivalent to Tecfidera®) has been officially approved by US FDA
2020.08
TWi officially launches generic Propafenone HCl ER Capsules in TWi label
2020.07
TWi officially launches generic Terbutaline Sulfate Tablets in TWi label
2020.07
TWi successfully launches generic Fenofibric Acid DR Capsules in TWi label
2020.06
TWi's ANDA for Terbutaline Sulfate Tablets (equivalent to Brethine®) has been officially approved by US FDA